|
Henry Schein, Inc. (HSIC) DCF -Bewertung
US | Healthcare | Medical - Distribution | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Henry Schein, Inc. (HSIC) Bundle
Entdecken Sie den tatsächlichen Wert von Henry Schein, Inc. (HSIC) mit unserem DCF-Taschenrechner von professionellem Grade! Passen Sie die wichtigsten Annahmen an, erkunden Sie verschiedene Szenarien und bewerten Sie, wie unterschiedliche Veränderungen die Bewertung von Henry Schein beeinflussen - alles innerhalb einer einzigen Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,119.1 | 12,401.0 | 12,647.0 | 12,339.0 | 12,673.0 | 13,458.9 | 14,293.5 | 15,179.9 | 16,121.2 | 17,121.0 |
| Revenue Growth, % | 0 | 22.55 | 1.98 | -2.44 | 2.71 | 6.2 | 6.2 | 6.2 | 6.2 | 6.2 |
| EBITDA | 726.8 | 1,067.7 | 1,090.0 | 877.0 | 941.0 | 1,048.3 | 1,113.3 | 1,182.3 | 1,255.6 | 1,333.5 |
| EBITDA, % | 7.18 | 8.61 | 8.62 | 7.11 | 7.43 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 |
| Depreciation | 185.5 | 209.5 | 212.0 | 248.0 | 297.0 | 257.1 | 273.1 | 290.0 | 308.0 | 327.1 |
| Depreciation, % | 1.83 | 1.69 | 1.68 | 2.01 | 2.34 | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 |
| EBIT | 541.3 | 858.1 | 878.0 | 629.0 | 644.0 | 791.1 | 840.2 | 892.3 | 947.6 | 1,006.4 |
| EBIT, % | 5.35 | 6.92 | 6.94 | 5.1 | 5.08 | 5.88 | 5.88 | 5.88 | 5.88 | 5.88 |
| Total Cash | 421.2 | 118.0 | 117.0 | 171.0 | 122.0 | 225.8 | 239.8 | 254.6 | 270.4 | 287.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1,424.8 | 1,451.8 | 1,442.0 | 1,863.0 | 1,482.0 | 1,722.3 | 1,829.1 | 1,942.5 | 2,062.9 | 2,190.9 |
| Account Receivables, % | 14.08 | 11.71 | 11.4 | 15.1 | 11.69 | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 |
| Inventories | 1,512.5 | 1,861.1 | 1,963.0 | 1,815.0 | 1,810.0 | 2,004.5 | 2,128.8 | 2,260.8 | 2,401.0 | 2,549.9 |
| Inventories, % | 14.95 | 15.01 | 15.52 | 14.71 | 14.28 | 14.89 | 14.89 | 14.89 | 14.89 | 14.89 |
| Accounts Payable | 1,005.7 | 1,053.9 | 1,004.0 | 1,020.0 | 962.0 | 1,136.8 | 1,207.3 | 1,282.2 | 1,361.7 | 1,446.1 |
| Accounts Payable, % | 9.94 | 8.5 | 7.94 | 8.27 | 7.59 | 8.45 | 8.45 | 8.45 | 8.45 | 8.45 |
| Capital Expenditure | -48.8 | -79.0 | -96.0 | -187.0 | -187.0 | -131.1 | -139.2 | -147.8 | -157.0 | -166.8 |
| Capital Expenditure, % | -0.48254 | -0.63717 | -0.75907 | -1.52 | -1.48 | -0.97398 | -0.97398 | -0.97398 | -0.97398 | -0.97398 |
| Tax Rate, % | 23.98 | 23.98 | 23.98 | 23.98 | 23.98 | 23.98 | 23.98 | 23.98 | 23.98 | 23.98 |
| EBITAT | 437.2 | 652.0 | 655.2 | 482.8 | 489.6 | 607.8 | 645.5 | 685.5 | 728.1 | 773.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1,357.7 | 455.1 | 629.2 | 286.8 | 927.6 | 473.9 | 618.8 | 657.1 | 697.9 | 741.2 |
| WACC, % | 7.22 | 7.17 | 7.15 | 7.18 | 7.17 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 2,567.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 756 | |||||||||
| Terminal Value | 14,600 | |||||||||
| Present Terminal Value | 10,324 | |||||||||
| Enterprise Value | 12,891 | |||||||||
| Net Debt | 2,748 | |||||||||
| Equity Value | 10,143 | |||||||||
| Diluted Shares Outstanding, MM | 128 | |||||||||
| Equity Value Per Share | 79.38 |
What You Will Get
- Real HSIC Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Instant Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Henry Schein's future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Data: Henry Schein, Inc.'s (HSIC) historical financial statements and pre-filled projections.
- Customizable Parameters: Adjust inputs such as WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Instantly view the intrinsic value of Henry Schein, Inc. (HSIC) recalculating as changes are made.
- Visual Data Representation: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Henry Schein data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Henry Schein’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Henry Schein, Inc. (HSIC)?
- Designed for Experts: A sophisticated tool utilized by healthcare analysts, CFOs, and industry consultants.
- Accurate Financial Data: Henry Schein’s historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step instructions help you navigate the process seamlessly.
Who Should Use This Product?
- Investors: Accurately assess Henry Schein’s fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
- Consultants: Efficiently customize the template for client valuation reports.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading companies.
- Educators: Employ it as a teaching resource to illustrate valuation techniques.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Henry Schein historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Henry Schein, Inc. (HSIC).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.